<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pkgmetadata SYSTEM "http://www.gentoo.org/dtd/metadata.dtd">
<pkgmetadata>
	<longdescription>
		Comprehensive Tools for Running Model-Assisted Phase I/II Trial
		Simulations // Provides a comprehensive set of tools to
		simulate, evaluate, and compare model-assisted designs for
		early-phase (Phase I/II) clinical trials, including: - BOIN12
		(Bayesian optimal interval phase 1/11 trial design; Lin et al.
		(2020) doi:10.1200/PO.20.00257), - BOIN-ET (Takeda, K., Taguri,
		M.,  Morita, S. (2018) doi:10.1002/pst.1864), - EffTox (Thall,
		P. F.,  Cook, J. D. (2004)
		doi:10.1111/j.0006-341X.2004.00218.x), - Ji3+3 (Joint i3+3
		design; Lin, X.,  Ji, Y. (2020)
		doi:10.1080/10543406.2020.1818250), - PRINTE (probability
		intervals of toxicity and efficacy design; Lin, X.,  Ji, Y.
		(2021) doi:10.1177/0962280220977009), - STEIN (simple toxicity
		and efficacy interval design; Lin, R.,  Yin, G. (2017)
		doi:10.1002/sim.7428), - TEPI (toxicity and efficacy
		probability interval design; Li, D. H., Whitmore, J. B., Guo,
		W.,  Ji, Y. (2017) doi:10.1158/1078-0432.CCR-16-1125), - uTPI
		(utility-based toxicity Probability interval design; Shi, H.,
		Lin, R.,  Lin, X. (2024) doi:10.1002/sim.8922). Includes
		flexible simulation parameters that allow researchers to
		efficiently compute operating characteristics under various
		fixed and random trial scenarios and export the results.
	</longdescription>
</pkgmetadata>
